42 related articles for article (PubMed ID: 21695793)
1. Retroviral expression of MIR2 decreases both surface MHC class I and the alloimmune CTL response.
Thakur A; Hummel J; Sengupta R; Gupta V; Mossman K; Jones K
J Tissue Eng Regen Med; 2011 Jul; 5(7):520-8. PubMed ID: 21695793
[TBL] [Abstract][Full Text] [Related]
2. Suppression of MHC class I antigens in oncogenic transformants: association with decreased recognition by cytotoxic T lymphocytes.
Seliger B; Harders C; Wollscheid U; Staege MS; Reske-Kunz AB; Huber C
Exp Hematol; 1996 Sep; 24(11):1275-9. PubMed ID: 8862437
[TBL] [Abstract][Full Text] [Related]
3. Minor histocompatibility antigens, defined by graft-vs.-host disease-derived cytotoxic T lymphocytes, show variable expression on human skin cells.
De Bueger M; Bakker A; Van Rood JJ; Goulmy E
Eur J Immunol; 1991 Nov; 21(11):2839-44. PubMed ID: 1682155
[TBL] [Abstract][Full Text] [Related]
4. Control of human herpes virus type 8-associated diseases by NK cells.
Sirianni MC; Campagna M; Scaramuzzi D; Carbonari M; Toschi E; Bacigalupo I; Monini P; Ensoli B
Ann N Y Acad Sci; 2007 Jan; 1096():37-43. PubMed ID: 17405914
[TBL] [Abstract][Full Text] [Related]
5. Expression of B7.1 (CD80) in a renal cell carcinoma line allows expansion of tumor-associated cytotoxic T lymphocytes in the presence of an alloresponse.
Schendel DJ; Frankenberger B; Jantzer P; Cayeux S; Nöbetaner E; Willimsky G; Maget B; Pohla H; Blankenstein T
Gene Ther; 2000 Dec; 7(23):2007-14. PubMed ID: 11175312
[TBL] [Abstract][Full Text] [Related]
6. Enrichment of an antigen-specific T cell response by retrovirally transduced human dendritic cells.
Heemskerk MH; Hooijberg E; Ruizendaal JJ; van der Weide MM; Kueter E; Bakker AQ; Schumacher TN; Spits H
Cell Immunol; 1999 Jul; 195(1):10-7. PubMed ID: 10433792
[TBL] [Abstract][Full Text] [Related]
7. Feline herpesvirus-1 down-regulates MHC class I expression in an homologous cell system.
Montagnaro S; Longo M; Pacilio M; Indovina P; Roberti A; De Martino L; Iovane G; Pagnini U
J Cell Biochem; 2009 Jan; 106(1):179-85. PubMed ID: 19009565
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the T cell-mediated cellular cytotoxicity during acute infectious mononucleosis.
Tomkinson BE; Maziarz R; Sullivan JL
J Immunol; 1989 Jul; 143(2):660-70. PubMed ID: 2472449
[TBL] [Abstract][Full Text] [Related]
9. Use of a lentiviral vector encoding a HCMV-chimeric IE1-pp65 protein for epitope identification in HLA-Transgenic mice and for ex vivo stimulation and expansion of CD8(+) cytotoxic T cells from human peripheral blood cells.
Rohrlich PS; Cardinaud S; Lulè J; Montero-Julian FA; Prodhomme V; Firat H; Davignon JL; Perret E; Monseaux S; Necker A; Michelson S; Lemonnier FA; Charneau P; Davrinche C
Hum Immunol; 2004 May; 65(5):514-22. PubMed ID: 15172452
[TBL] [Abstract][Full Text] [Related]
10. Studies on the induction and expression of T cell-mediated immunity. XV. Role of non-MHC papain-sensitive target structures and Lyt-2 antigens in allogeneic and xenogeneic lectin-dependent cellular cytotoxicity (LDCC).
Bonavida B; Katz J
J Immunol; 1985 Sep; 135(3):1616-23. PubMed ID: 3874903
[TBL] [Abstract][Full Text] [Related]
11. The immunogenic potential of human fetal retinal pigment epithelium and its relation to transplantation.
Rezai KA; Semnani RT; Patel SC; Ernest JT; van Seventer GA
Invest Ophthalmol Vis Sci; 1997 Nov; 38(12):2662-71. PubMed ID: 9375586
[TBL] [Abstract][Full Text] [Related]
12. B7-1 expression decreases tumorigenicity and induces partial systemic immunity to murine neuroblastoma deficient in major histocompatibility complex and costimulatory molecules.
Katsanis E; Xu Z; Bausero MA; Dancisak BB; Gorden KB; Davis G; Gray GS; Orchard PJ; Blazar BR
Cancer Gene Ther; 1995 Mar; 2(1):39-46. PubMed ID: 7542553
[TBL] [Abstract][Full Text] [Related]
13. A retroviral vector system 'STITCH' in combination with an optimized single chain antibody chimeric receptor gene structure allows efficient gene transduction and expression in human T lymphocytes.
Weijtens ME; Willemsen RA; Hart EH; Bolhuis RL
Gene Ther; 1998 Sep; 5(9):1195-203. PubMed ID: 9930320
[TBL] [Abstract][Full Text] [Related]
14. Immune selection in murine tumors. Ph.d thesis.
Svane IM; Engel AM
APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
[TBL] [Abstract][Full Text] [Related]
15. T cell-accessory cell interactions that initiate allospecific cytotoxic T lymphocyte responses: existence of both Ia-restricted and Ia-unrestricted cellular interaction pathways.
Singer A; Kruisbeek AM; Andrysiak PM
J Immunol; 1984 May; 132(5):2199-209. PubMed ID: 6201534
[TBL] [Abstract][Full Text] [Related]
16. Adenoviral vector expressing ICP47 inhibits adenovirus-specific cytotoxic T lymphocytes in nonhuman primates.
Scaria A; Sullivan JA; St George JA; Kaplan JM; Lukason MJ; Morris JE; Plog M; Nicolette C; Gregory RJ; Wadsworth SC
Mol Ther; 2000 Nov; 2(5):505-14. PubMed ID: 11082324
[TBL] [Abstract][Full Text] [Related]
17. Lytic susceptibility of target cells to cytotoxic T cells is determined by their constitutive major histocompatibility complex class I antigen expression and cytokine-induced activation status.
Ritter M; Huber C; Auböck J; Pohl-Markl H; Troppmair J; Herold M; Gächter A; Nussbaumer W; Böck G; Nachbaur D
Immunology; 1994 Apr; 81(4):569-77. PubMed ID: 7913694
[TBL] [Abstract][Full Text] [Related]
18. Peptide loading of empty major histocompatibility complex molecules on RMA-S cells allows the induction of primary cytotoxic T lymphocyte responses.
De Bruijn ML; Schumacher TN; Nieland JD; Ploegh HL; Kast WM; Melief CJ
Eur J Immunol; 1991 Dec; 21(12):2963-70. PubMed ID: 1660811
[TBL] [Abstract][Full Text] [Related]
19. K3-mediated evasion of CD8(+) T cells aids amplification of a latent gamma-herpesvirus.
Stevenson PG; May JS; Smith XG; Marques S; Adler H; Koszinowski UH; Simas JP; Efstathiou S
Nat Immunol; 2002 Aug; 3(8):733-40. PubMed ID: 12101398
[TBL] [Abstract][Full Text] [Related]
20. Retroviral vector backbone immunogenicity: identification of cytotoxic T-cell epitopes in retroviral vector-packaging sequences.
Kondo E; Akatsuka Y; Nawa A; Kuzushima K; Tsujimura K; Tanimoto M; Kodera Y; Morishima Y; Kuzuya K; Takahashi T
Gene Ther; 2005 Feb; 12(3):252-8. PubMed ID: 15496958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
